comparemela.com
Home
Live Updates
Shenzhen Arimab Biopharmaceuticals Co Ltd - Breaking News
Pages:
Latest Breaking News On - Shenzhen arimab biopharmaceuticals co ltd - Page 1 : comparemela.com
Aridis Pharmaceuticals : Termination of Material Agreement - Form 8-K -Today at 05:16 pm
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT .
United states
Los gatos
Vu truong
Shenzhen hepalink pharmaceutical group co ltd
Securities exchange
Aridis pharmaceuticals inc
Shenzhen arimab biopharmaceuticals co ltd
Exchange act
Securities act
Securities exchange act
Material definitive
Aridis pharmaceuticals
Restated technology license
Collaboration agreement
Aridis Pharmaceuticals Announces 2021 Fourth Quarter and Year-End Financial Results and Business Update
/PRNewswire/ Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective.
Los gatos
Vu truong
Aridis pharmaceuticals
Aridis pharmaceuticals inc
Prnewswire aridis pharmaceuticals inc
Cystic fibrosis foundation
Innovative medicines initiative
Development expenses
Us small business administration
Paycheck protection program
Serum institute of india
Clinical program
Redchip companies
Company phase
Melinda gates foundation
European commission
vimarsana © 2020. All Rights Reserved.